Foundation Medicine Files Registration Statement for Proposed Initial Public Offering of Common Stock

CAMBRIDGE, MA. July 29, 2013 - Foundation Medicine, Inc. today announced the filing of a Registration Statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. All of the shares to be sold in the proposed offering will be offered by Foundation Medicine. Foundation Medicine has applied for a listing of its common stock on The NASDAQ Stock Market under the symbol "FMI".

Goldman, Sachs & Co. and J.P. Morgan Securities, LLC will act as joint book-running managers of the offering. A copy of the preliminary prospectus relating to this offering may be obtained, when available, from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526, facsimile at (212) 902-9316, or e-mail at prospectus-ny@ny.email.gs.com; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Contacts:

Media - Foundation Medicine
Dan Budwick
Pure Communications, Inc.
(973)271-6085

Investors - Foundation Medicine
Matt Clawson
(617)418-2283